Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 2

Status

Completed 78Terminated 38Recruiting 35Active not recruiting 17Unknown 9Withdrawn 8Not yet recruiting 5

Sponsor Class

INDUSTRY 3OTHER 2

Study Type

Interventional 5

Sponsor

Cancer Type

Thoracic 5

Conditions

Carcinoma, Non-Small-Cell Lung 26Lung Neoplasms 5Small Cell Lung Carcinoma 2Pancreatic Neoplasms 2Neoplasm Metastasis 2NSCLC 2Brain Neoplasms 2Solid Tumor Cancer 1Non-squamous Non-small Cell Lung Cancer 1Non-small Cell Lung Cancer Metastatic 1Non Squamous Non-small Cell Lung Cancer 1Neoplasms 1Mesothelioma, Malignant 1Meningeal Carcinomatosis 1Melanoma 1Lymphatic Metastasis 1Lung Non-Squamous Non-Small Cell Carcinoma 1Lung Diseases, Interstitial 1Gastrointestinal Neoplasms 1Esophageal Neoplasms 1Disease Progression 1Diabetes Mellitus, Insulin-Dependent, 12 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma 1Advanced Solid Tumor 1Adenocarcinoma of Lung 1

Interventions

Specimen Handling 9Magnetic Resonance Spectroscopy 8Drug Therapy 7Carboplatin 7osimertinib 6Tomography, X-Ray Computed 5Pemetrexed 5Educational Status 4Cisplatin 4Blood Specimen Collection 4cemiplimab 3Interviews as Topic 3Injections 3Exercise 3Early Intervention, Educational 3pembrolizumab 2durvalumab 2atezolizumab 2anlotinib 2aflutinib 2Surgical Procedures, Operative 2Standard of Care 2Radiotherapy 2Radiosurgery 2Observation 2Nivolumab 2Methods 2Magnetic Resonance Imaging 2Immunotherapy 2Etoposide 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Not yet recruiting × Lung Neoplasms × Pemetrexed × Clear all
NCT07486817 2026-05-19

Beamion 44: A Study to Test How Well Zongertinib is Tolerated by People With Advanced Non-small Cell Lung Cancer With HER2 Mutations When Given in Combination With Chemotherapy With or Without Pembrolizumab

Boehringer Ingelheim

Phase 2 Not yet recruiting
60 enrolled
Thoracic

Lung Neoplasms

NCT07405190 2026-02-12

Ivonescimab Alone And With Carboplatin/Pemetrexed For NSCLC

Massachusetts General Hospital

Phase 2 Not yet recruiting
46 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07154368 2025-09-19

JYP0322 Versus Platinum Based Doublet Chemotherapy in ROS1 Positive Patients Previously Treated With ROS1-TKIs.

Guangzhou JOYO Pharma Co., Ltd

Phase 3 Not yet recruiting
207 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06970782 2025-05-21

KYLIN-3

Avistone Biotechnology Co., Ltd.

Phase 3 Not yet recruiting
278 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06688656 2024-11-14

Peri-E

Shanghai Chest Hospital

Phase 2 Not yet recruiting
30 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡